Licensed Practical Nurse in Northampton, MA Accepting Medicare

4 Licensed Practical Nurse nurses found. Showing 1 - 4

Denise Spencer, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Atwood Dr, Northampton, MA 01060 Phone: 413-773-1314

Wendy Ann Loudon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 441 Pleasant St, Northampton, MA 01060 Phone: 413-584-2404    Fax: 413-585-8631

Shirley Wohlander, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Atwood Drive, Northampton, MA 01062 Phone: 413-773-1314

Theresa Dion, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 441 Pleasant St, Northampton, MA 01060 Phone: 413-584-2404

News Archive

Tibotec reports Phase 3 trial results of TMC278 vs. EFV in treatment-naive HIV-1-infected adults

Tibotec Pharmaceuticals announced today results from two pivotal Phase 3, double-blind, randomized clinical trials comparing the efficacy, safety and tolerability of its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC278 (rilpivirine) versus efavirenz (EFV), each administered once daily with a nucleoside/nucleotide background regimen in treatment-naive, HIV-1-infected adults.

Language used to describe alcohol intoxication may give insight into drinking habits

People have always used different words to describe the inebriating effects of alcohol, from "blotto" in the 1920s to "honkers" in the 1950s. Now, new Penn State research suggests the language young adults use to describe the effects they feel from drinking may give insight into their drinking habits.

Omnicell's OmniCenter qualifies for VMware Ready logo

Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that its OmniCenter® server has achieved VMware Ready™ status. This designation indicates that OmniCenter has passed a detailed evaluation and testing process managed by VMware and is now listed on the VMware Partner Product Catalog.

NIDA grants Selecta Biosciences $3M to develop nicotine vaccine for smoking cessation and relapse prevention

Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health. The grant is aimed at advancing the development of an enhanced therapeutic nicotine vaccine for the treatment of smoking cessation and relapse prevention.

UH physicists study workings of PGK enzyme that may cause Alzheimer's, cancer

University of Houston physicists are using complex computer simulations to illuminate the workings of a crucial protein that, when malfunctioning, may cause Alzheimer's and cancer.

Read more Medical News

› Verified 2 days ago